Cargando…
Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient
Autores principales: | Fakharian, Atefeh, Barati, Saghar, Mohamadi, Monir, Dastan, Farzaneh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833423/ https://www.ncbi.nlm.nih.gov/pubmed/33423911 http://dx.doi.org/10.1053/j.jvca.2020.12.023 |
Ejemplares similares
-
Evaluating the Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation following Coronary Artery Bypass Graft Surgery: A Randomised Controlled Trial
por: Dastan, Farzaneh, et al.
Publicado: (2023) -
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
por: Fakharian, Atefeh, et al.
Publicado: (2021) -
Evaluating the Effect of Acetazolamide on the Prevention of Post-operative Acute Kidney Injury after Coronary Artery Bypass Grafting Surgery: A Randomized, Open-labeled Clinical Trial
por: Afzal, Golnaz, et al.
Publicado: (2021) -
Potential Effect of L-Carnitine on the Prevention of Myocardial Injury after Coronary Artery Bypass Graft Surgery
por: Dastan, Farzaneh, et al.
Publicado: (2015) -
Study of the Effects of Melatonin on Sleep Disorders in Pulmonary Sarcoidosis Patients
por: Feizabadi, Faezeh, et al.
Publicado: (2023)